PFIZER INC. for PFIZER INC.

Taxation/Internal Revenue Code TAX

Repatriation Deferral Deferral for active-financing income- extension S. 1203 - R& D Tax Credit Extension and Enhancement H.R. 422 - R&D Tax Credit Extension and Enhancement H.R. 2098 - CFC Look Through Extension

Contacted: Patent & Trademark Office (PTO); Executive Office of the President (EOP); State, Dept of (DOS); SENATE; Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Bills named: S. 1203 (112th), H.R. 2098 (112th), H.R. 422 (112th)

Health Issues HCR

Health Care Reform Comparative Effectiveness Research Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Antibiotic Incentives Tax Extenders Antimicrobial Resistance Strategies to Address Antimicrobial Resistance H.R. 965 The Preservation of Antibiotics for Medical Treatment Act, 2011 H.R. 979 FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act, 2011 H.R. 452 Medicare Decision Accountability Act, 2011 S. 668 Health Care Bureacrats Elimination Act, 2011

Contacted: State, Dept of (DOS); Patent & Trademark Office (PTO); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); Executive Office of the President (EOP); SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 979 (112th), S. 668 (112th), H.R. 452 (112th), H.R. 965 (112th)

Medicare/Medicaid MMM

Medicare Prescription Drug Benefit Medicaid Rebates Medicare Coverage Average Manufacturer Price Regulation Patient Protection and Affordable Care Act Implementation

Contacted: Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Patent & Trademark Office (PTO); Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); Executive Office of the President (EOP); SENATE

Consumer Issues/Safety/Products CSP

Importation The Food, Drug and Cosmetic Globalization Act Dextromethorphan Distribution Dextromethorphan Abuse Reduction H.R. 741 - Act to Prohibit the Marketing of Authorized Generic Drugs, 2011 S. 373 - Fair Prescription Drug Competition Act, 2011

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); State, Dept of (DOS); Food & Drug Administration (FDA); Executive Office of the President (EOP); Commerce, Dept of (DOC); Patent & Trademark Office (PTO); SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 373 (112th), H.R. 741 (112th)

Copyright/Patent/Trademark CPT

Counterfeit Pharmaceuticals Expert Patent Courts Pilot Programs Patent Settlements Patent Reform Act, 2011 Protecting Consumer Access to Generic Drugs S.23 - America Invents Act, 2011 S. 27 - Preserve Access to Affordable Generics H.R. 1249 - America Invents Act, 2011

Contacted: SENATE; State, Dept of (DOS); Food & Drug Administration (FDA); Executive Office of the President (EOP); Patent & Trademark Office (PTO); Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 23 (112th), H.R. 1249 (112th), S. 27 (112th)

Trade (domestic/foreign) TRD

Trans Pacific Partnership Negotiations US - EU Dialogues (TEC) - market access and regulatory issues Japan Market Access and Regulatory Issues US-Korea Free Trade Agreement Russia market access (no bills) Israel Patent Issues (no bills) APEC Life Sciences Innovation Forum Brazil IP Thailand Compulsory Licensing India IP and Market Access issues Australian FTA Implementation Special 301 Reform Legislation

Contacted: Executive Office of the President (EOP); SENATE; Centers For Medicare and Medicaid Services (CMS); Patent & Trademark Office (PTO); State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); Food & Drug Administration (FDA)